# McKesson Corporation (MCK)

**Exchange:** NYSE  
**Sector:** Healthcare  
**Market cap:** $97.69B  
**Price:** $787.19 (-0.41%)

> McKesson Corporation is a healthcare services company that supports the flow of medicines, supplies, and related solutions across the healthcare system. The company operates through North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions, serving pharmacies, health systems, physician practices, post-acute care providers, and other care settings. Its pharmaceutical distribution business supplies branded, generic, specialty, biosimilar, and over-the-counter products, while its medical-surgical operations provide clinical supplies, logistics, and equipment support. McKesson also offers technology-enabled services that help healthcare organizations manage prescriptions, practice operations, and patient care workflows. Through its broad distribution network and service platforms, McKesson plays a central role in connecting manufacturers, providers, and pharmacies across the U.S. and internationally.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $403.43B | $14.55B | $6.21B | $4.76B | — |
| 2025 | $359.05B | $13.32B | $4.42B | $3.29B | — |
| 2024 | $308.95B | $12.83B | $3.91B | $3.00B | — |
| 2023 | $276.71B | $12.36B | $4.38B | $3.56B | — |
| 2022 | $263.97B | $13.13B | $2.04B | $1.11B | — |
| 2021 | $238.23B | $12.15B | -$5.04B | -$4.54B | — |
| 2020 | $231.05B | $12.02B | $2.49B | $900M | — |
| 2019 | $214.32B | $11.75B | $886M | $34M | — |
| 2018 | $208.36B | $11.18B | $762M | $67M | — |
| 2017 | $198.53B | $11.27B | $7.12B | $5.07B | — |
| 2016 | $190.88B | $11.42B | $3.54B | $2.26B | — |
| 2015 | $179.04B | $11.41B | $2.97B | $1.48B | — |
| 2014 | $137.39B | $8.35B | $2.44B | $1.26B | — |
| 2013 | $122.20B | $6.88B | $2.35B | $1.34B | — |
| 2012 | $122.32B | $6.40B | $2.12B | $1.40B | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2026 | $82.32B | $84.50B | -$2.17B | $3.98B | $6.53B |
| 2025 | $75.14B | $77.21B | -$2.07B | $5.69B | $5.65B |
| 2024 | $67.44B | $69.41B | -$1.97B | $4.58B | $5.63B |
| 2023 | $62.32B | $64.18B | -$1.86B | $4.68B | $5.59B |
| 2022 | $63.30B | $65.57B | -$2.27B | $3.53B | $5.88B |
| 2021 | $65.02B | $65.04B | -$21M | $6.28B | $7.15B |
| 2020 | $61.25B | $56.16B | $5.09B | $4.01B | $7.39B |
| 2019 | $59.67B | $51.58B | $8.09B | $2.98B | $7.59B |
| 2018 | $60.38B | $50.58B | $9.80B | $2.67B | $7.88B |
| 2017 | $60.97B | $49.87B | $11.10B | $2.78B | $8.36B |
| 2016 | $56.52B | $47.60B | $8.92B | $4.05B | $8.11B |
| 2015 | $53.87B | $45.87B | $8.00B | $5.34B | $9.71B |
| 2014 | $51.76B | $43.24B | $8.52B | $4.19B | $10.35B |
| 2013 | $34.79B | $27.72B | $7.07B | $2.46B | $4.87B |
| 2012 | $33.09B | $26.26B | $6.83B | $3.15B | $3.58B |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2026 | $6.16B | $436M | $5.72B |
| 2025 | $6.08B | $537M | $5.55B |
| 2024 | $4.31B | $431M | $3.88B |
| 2023 | $5.16B | $390M | $4.77B |
| 2022 | $4.43B | $388M | $4.05B |
| 2021 | $4.54B | $451M | $4.09B |
| 2020 | $4.37B | $362M | $4.01B |
| 2019 | $4.04B | $426M | $3.61B |
| 2018 | $4.34B | $405M | $3.94B |
| 2017 | $4.74B | $404M | $4.34B |
| 2016 | $3.67B | $488M | $3.18B |
| 2015 | $3.11B | $376M | $2.74B |
| 2014 | $3.14B | $278M | $2.86B |
| 2013 | $2.48B | $241M | $2.24B |
| 2012 | $2.95B | $221M | $2.73B |

Source: [CompaniesByCap](https://companiesbycap.com/company/MCK)